Oruka Therapeutics, Inc.
Clinical trials sponsored by Oruka Therapeutics, Inc., explained in plain language.
-
Two-Year psoriasis treatment trial seeks to prove lasting relief
Disease control Recruiting nowThis study aims to learn about the long-term safety and effectiveness of an investigational medication called ORKA-001 for adults with moderate-to-severe plaque psoriasis. It is open only to people who have already taken ORKA-001 in a previous company-sponsored study. Participant…
Phase: PHASE2 • Sponsor: Oruka Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug trial aims to clear severe skin plaques
Disease control Recruiting nowThis study is testing a new drug called ORKA-001 to see if it can clear skin plaques in people with moderate-to-severe plaque psoriasis. About 160 adults will receive either the drug or a placebo to find the best dose and check how safe it is. The main goal is to see how many peo…
Phase: PHASE2 • Sponsor: Oruka Therapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC